Related Experiment Video
Updated: Apr 19, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
[Axillary hyperhidrosis, botulinium A toxin treatment: Review]
C Clerico1, J Fernandez1, O Camuzard1
1Service de chirurgie plastique, reconstructrice et chirurgie de la main, hôpital Saint-Roch, rue Pierre-Devoluy, 06000 Nice, France.
Botulinum toxin type A injections offer a safe and effective temporary treatment for axillary hyperhidrosis (excessive underarm sweating). This review examines its efficacy and compares it with other therapeutic options.
Area of Science:
- Dermatology
- Neurology
- Medical Aesthetics
Background:
- Axillary hyperhidrosis is a condition causing excessive underarm sweating.
- This condition can be socially disabling for affected individuals.
- Botulinum toxin type A injections have emerged as a treatment option.
Purpose of the Study:
- To review existing data on treating axillary hyperhidrosis with botulinum toxin type A.
- To discuss the efficacy and safety of this treatment modality.
- To compare botulinum toxin type A with alternative treatments for axillary hyperhidrosis.
Main Methods:
- Literature review of studies on botulinum toxin type A for axillary hyperhidrosis.
- Analysis of data regarding treatment efficacy and safety.
- Discussion of various treatment modalities.
Main Results:
- Botulinum toxin type A injections are recognized as an efficient and safe temporary treatment.
- The technique was initially described in 1996.
- Data supports its effectiveness in managing axillary hyperhidrosis.
Conclusions:
- Botulinum toxin type A is a viable treatment for axillary hyperhidrosis.
- Further discussion on alternative treatments is warranted.
- Managing this socially disabling condition is crucial.
More Related Videos
12:25Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
10:30A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Skeletal Muscle Relaxants: Therapeutic Uses
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Depolarizing Blockers: Pharmocokinetics
Assessing Body Temperature - Axilla
Step 1: Perform hand hygiene and put on clean gloves to maintain infection control and prevent cross-contamination.
Step 2: Prepare the patient by explaining the procedure to ensure understanding and cooperation. Ensure privacy, expose the axilla, and inform the patient that minimal movement is crucial for an accurate reading.
Step 3: Adjust the patient’s clothing to expose only the axilla. It minimizes...